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Abstract (199 words, max 200)
Aims  :  The aim of this study was to compare the stent strut apposition and stent induced 
vessel  wall  stresses  of  currently  used  coronary  stent  designs.  This  may  help  to  better 
understand  their  clinical  performance  and  provide  the  insights  necessary  for  further 
optimization.
Methods   and results:  We compared the stent strut apposition of six different stent designs 
when  implanted  in  a  stenosed  vessel  using  a  novel  approach  based  on  finite  element 
simulations. Additional insights into the mechanical behaviour of the investigated stents were 
obtained by virtually quantifying the stent induced vessel wall stresses. For the investigated 
stenosed vessel model,  the percentage of  malapposed struts (distance to wall  > 10  µm) 
ranged between 9% (Integrity stent) and 43% (Promus Element stent).  The largest strut-
artery distances were observed at the plaque shoulders. The 95 percentile of the axial stress 
within the intima ranges from 32 (Promus Element stent) to 83 kPa (Liberté stent). Stress 
peaks were mainly located at the inner curvatures of the vessel model and at the stent ends.
Conclusions: The mechanical  behaviour  of  the investigated stents differs  considerably  in 
terms of stent strut apposition and stent induced vessel wall stresses. These differences in 
mechanical behaviour might influence clinical performance.
Keywords
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Condensed abstract (100 words, max 500 char)
Incomplete strut apposition has been associated with higher levels of thrombus deposition. A 
better understanding of how stent design influences strut apposition is therefore essential. 
We  studied  the  strut  apposition  of  six  stent  designs  using  computer  simulations.  The 
percentage of malapposed struts ranged between 9% (Integrity) and 43% (Promus Element). 
The largest strut-artery distances were observed at the plaque shoulders. In conclusion, the 
mechanical behaviour of the investigated stents differs considerably and these differences 
might influence clinical performance.
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Abbreviations list
BMS (Bare Metal Stent)
DES (Drug-Eluting Stent)
ISA (Incomplete Stent Apposition)
IVUS (IntraVascular UltraSound)
OCT (Optical Coherence Tomography)
CT (Computed Tomography)
MLA (Minimal Luminal Area)
MLD (Minimal Luminal Diameter)
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Introduction
The  design  of  bare  metal  stents  (BMS)  clearly  influences  the  immediate  and  long-term 
clinical outcome as shown by Kastrati et al. [1]. They compared five different uncoated stents 
of the same material during a randomized trial  and ascribed the significant differences in 
event-free survival at 1 year (ranging from 69.2% to 82.4%) to differences in stent design.  
The role of the design became less clear after the introduction of drug-eluting stents (DES). 
These devices consist  of multiple components (coating, drug and design) which makes it 
more complicated to assess the impact of one individual factor. The fact that all DES lead to 
low  restenosis  rates,  with  small  differences  between  the  available  products  [2],  also 
contributed to the reduced attention given to the design. However, research focusing on the 
design of stents remains justified because a further improvement of the clinical outcomes will 
only  be achieved  through  further  optimization  of  both  the  drug  delivery  system and  the 
underlying platform.
Many different stents are currently available on the market and the differences between the 
designs of these products are not always clear. Objective comparisons may help to better 
understand the clinical  performance of  the  available  products  and may also  provide the 
insights necessary for further optimization. We therefore evaluated the mechanical behaviour 
of six different stent platforms in terms of stent strut apposition and stent induced vessel wall 
stresses.
Incomplete stent apposition (ISA) or stent malapposition is the lack of contact between stent 
struts  and the underlying  arterial  wall.  ISA has been associated with  significantly  higher 
levels of thrombus deposition [3], but little is known about the role of the stent platform. In 
this paper, we propose a novel method based on advanced computer (i.e. finite element) 
simulations  to  investigate  the  phenomenon  of  ISA.  The  proposed  approach  allows 
quantification  and visualisation  of  ISA over  the  complete  stent  length,  in  contrast  to  the 
currently used techniques such as intravascular ultrasound (IVUS) [4] or optical coherence 
tomography (OCT) [5] that only give information in a limited number of cross-sections.
Stent induced vessel wall stresses were also quantified for the six different stent designs 
using a similar computational approach. These stresses should ideally be low as it has been 
suggested that high stresses cause vessel injury and may act as a chronic stimulus for cell  
proliferation [6].
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Materials and methods
Stents
The following stents were evaluated in this study: (i) Integrity stent (Medtronic, Minneapolis, 
MN, USA), (ii) Liberté or Veriflex stent (Boston Scientific, Natick, MA, USA), (iii) Multi-Link 8 
stent (Abbott Vascular, Santa Clara, CA, USA) (iv) Multi-Link Vision stent (Abbott Vascular), 
(v)  Pro-Kinetic  Energy  stent  (Biotronik,  Bülach,  Switzerland),  (vi)  Promus  Element  stent 
(Boston Scientific). Table 1 contains information on the stent dimensions and alloys and links 
the investigated BMS to their corresponding drug-eluting version (and vice versa).
One sample of each stent was scanned in its crimped state at two different resolutions. All  
scans were performed using a Nikon XT H 225 CT system which consists of a Nikon open 
type  X-ray  tube  (Nikon  Metrology,  Leuven,  Belgium)  and  a  Paxscan  2520V  X-ray 
amorphous-Si  flat  panel  detector  (Varian  Imaging  Systems,  Palo  Alto,  CA,  USA).  The 
complete stent length, 16 or 18 mm, was scanned with a CT voxel size of 9.3 µm. Only 2 mm 
of  the total  stent length was scanned at the higher resolution (voxel  size of 1  µm). This 
resolution is required to obtain accurate information on the strut dimensions.
All unknown stent dimensions were derived from the low and high resolution micro-CT data 
of the crimped stents. This information was then used to generate virtual stent models with 
pyFormex  (www.pyformex.org)  that  accurately  represent  the  actual  geometries  of  the 
crimped stents (see, for example, [7]). Residual stresses induced by the crimping process 
were neglected.  Material  properties for  the four  different  metallic  alloys  were taken from 
O'Brien et al. [8]. All stents were meshed with linear hexahedral elements.
Folded balloon models
The compliance behaviour of the different balloons combined with the investigated stents 
was unknown,  and therefore,  the compliance behaviour  of  the balloon-stent  systems (as 
printed on the stent packaging) was used to estimate an initial value for the unfolded balloon 
diameters (at zero pressure) and Young's moduli. For all balloons, a five folded pattern and a 
uniform membrane thickness of 0.02 mm was used. All stents were then virtually deployed 
and  the  simulated  compliance  behaviour  was  compared  to  the  data  provided  by  the 
manufacturers. The unfolded balloon diameters (at zero pressure) and Young's moduli were 
adjusted until the virtual compliance behaviour was in satisfactory agreement with the data 
provided by the manufacturers.
Artery models
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Stent strut apposition was evaluated by virtually implanting the stents in a stenosed artery 
model, while the stent induced axial stresses were evaluated using a curved non-diseased 
vessel model (Fig. 1). An inner diameter of 2.9 mm was used for the non-diseased vessel 
segments. The outer wall diameter was taken 1.6 times larger than the inner diameter as this 
results in a realistic wall thickness according to the anatomical data published by Holzapfel et 
al. for non-atherosclerotic coronary arteries [9]. The layered structure of the arterial wall was 
taken into  account  and the ratios  of  adventitia,  media  and intima thickness to  total  wall 
thickness  were 0.37,  0.36 and  0.27,  based on  the work  of  Holzapfel  et  al.  [9].  For  the 
stenosed model, two asymmetric plaques were added, each characterized by a length of 3.9 
mm and a percent area stenosis of 61%. The curved sections of the tortuous vessel model 
have a radius of curvature of 12 mm. An anisotropic hyperelastic constitutive model was 
used to describe the mechanical behaviour of the three arterial layers [9]. This constitutive 
model was implemented as a user-defined material  (VUMAT) in Abaqus/Explicit  (Simulia, 
Providence, RI, USA) and the accuracy of the implementation has been demonstrated in a 
previous  study  [7].  Different  material  parameters  were  assigned  to  each  arterial  layer 
corresponding to Specimen I documented in [9].  An isotropic and hyperelastic third order 
Ogden constitutive model was used to describe the mechanical behaviour of the plaque [6]. 
The  vessel  geometry  and  the  corresponding  hexahedral  mesh  were  generated  using 
pyFormex.
Simulations
All stents were virtually deployed within the stenosed and the curved artery model as shown 
in  Fig.  2  using  the  Abaqus/Explicit  finite  element  solver.  The  stent  strut  apposition  was 
evaluated  for  the  stenosed  vessel  model  after  deflating  the  balloons  by  measuring  the 
distance from the centerline of the outer stent surface to the inner surface of the arterial wall. 
For the Integrity stent which has circular struts, the initial outermost point of the struts was 
taken for the distance measurements as indicated in Fig. 3.
 
The minimal luminal area (MLA) at the two stenoses was measured after balloon deflation. 
This  was  done  by  importing  the  deformed  luminal  cross-sections  into  pyFormex,  which 
contains  functionalities  to  characterize  two-dimensional  closed  curves.  Corresponding 
minimal  luminal  diameters  (MLD)  were  calculated  by  assuming  a  circular  shape  of  the 
luminal cross-sections.
The stent induced vessel wall stresses were measured for the curved vessel model after 
balloon deflation. In particular, the 95 percentile of the axial stresses within the intima was 
7
calculated and compared. Only 5% of the volume of the intima has a stress value higher than 
this 95 percentile.
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Results
Validation of the stent deployment behaviour
The accuracy of the compliance behaviour of the virtual balloon-stent systems was verified 
by comparing the simulation results with the data reported by the stent manufacturers. For all 
stents, the maximum percentage difference in diameter was less than 3% (for pressures up 
to 14 atm). A comparison of the virtual and a real deployment of the Integrity stent is depicted 
in Fig. 4. One can observe that the transient deployment behaviour (including the so-called 
dogboning effect) is well predicted by the finite element simulation.
Stent strut apposition
All stents were virtually implanted in the stenosed artery model. Based on these deformed 
configurations, the distance between the struts and the inner arterial wall was calculated in 
order to quantify the stent strut apposition.
The  contourplot  shown  in  Fig.  5  illustrates  the  stent  strut  apposition  of  the  different 
investigated stents. A blue color corresponds with a minimal distance between the struts and 
the inner arterial wall and thus with a good apposition of the stent struts whereas a red color 
reflects a larger strut-artery distance. The struts of all stents are well apposed at the location 
of  the stenoses. Severe malapposition,  if  present,  occurs mainly immediately proximal  or 
distal from the diseased segments.
The  percentage  of  struts  at  a  distance  larger  than  a  certain  threshold  can  easily  be 
calculated by dividing the length of  the centerline which is at a distance larger than this 
threshold by the total length of this centerline. This allows easy comparison of the different 
stents (see Fig. 6). The percentage of struts at a distance larger than 0.01 mm ranges from 
9% (Integrity stent) to 43% (Promus Element stent).
Luminal gain
The MLA was measured at the two stenoses and the average values are reported in Table 2 
together  with  the  derived  MLD.  The  two  extreme  MLA values  are  6.45  and  6.85  mm², 
corresponding with the Promus Element and Integrity stent.
Stent-induced vessel wall stresses
The 95 percentile  of  the axial  stress ranges from 32 (Promus Element  stent)  to 83 kPa 
(Liberté stent) as illustrated in Fig. 7. A contourplot of the axial stresses at the intima-media 
9
interface is shown in Fig. 8. It can be observed that the highest tensile stresses are located 
at the inner curvatures and at the stent ends. 
1
Discussion
Incomplete  stent  apposition  (ISA)  is  the  lack  of  contact  between  stent  struts  and  the 
underlying arterial wall not overlapping a side branch. Several mechanisms may lead to ISA 
and  a  distinction  should  be  made  between  acute  and  late  malapposition.  Acute 
malapposition occurs at the time of stent deployment and is more frequent with increasing 
lesion complexity (e.g.  calcified lesions,  larger vessels,  longer  lesions)  [10].  At  follow-up, 
initially malapposed struts can be well-apposed due to neointimal hyperplasia, or can remain 
malapposed (late persistent ISA). On the other hand, initially well-apposed struts may loose 
contact with the tissue because of positive remodelling of the vessel wall, or due to thrombus 
dissolution behind the struts (late acquired ISA) [11].
Late ISA has been significantly associated with the development of OCT-detected thrombus 
at follow-up [3]. Ozaki et al. hypothesized that the greater prevalence of attached thrombosis 
for incompletely apposed struts relative to well-apposed struts reflects the greater exposed 
surface  area  and  the  possible  flow  disturbances.  However,  the  clinical  relevance  of 
incomplete  stent  apposition  is  still  a  matter  of  debate.  Some  studies  suggested  that 
incomplete stent apposition plays a role in the pathogenesis of stent thrombosis [3, 12-13], 
while  other  studies  conclude  that  stent  malapposition  is  a  pure  IVUS  finding  without 
significant  impact  on the incidence of  major  adverse cardiac events [4,10-11,14-16].  The 
main limitation of all these studies is their inadequate statistical power. It is extremely difficult 
to demonstrate an association between a relatively uncommon occurrence (late ISA) and an 
even rarer event such as very late stent thrombosis [17]. 
In a recent study, Ozaki et al. [3] evaluated the mechanisms by which late ISA develops 
using both IVUS and OCT. They observed that 93% of the malapposed stent struts at follow-
up  were  also  initially  incompletely  apposed,  suggesting  that  late  persistent  ISA  is  the 
predominant mechanism for late ISA. Therefore, the incidence of late ISA can be significantly 
reduced by optimizing the acute apposition of the stent struts.
Our novel approach based on finite element simulations may help to better understand and 
to minimize acute ISA as it gives additional information compared to traditional evaluation 
methods (IVUS and OCT). The strut-artery distance can be quantified and visualized over 
the complete stent length, while currently used IVUS and OCT systems only give information 
in a limited number of cross-sections. In this way, the location of the malapposed struts can 
be identified and related to the artery and plaque morphology and the impact of different 
stent designs can be investigated.
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The  strut  apposition  of  the  different  investigated  stent  designs  differs  considerably  as 
illustrated in Fig. 5 and 6. The Liberté, Multi-Link 8, Multi-Link Vision and Pro-Kinetic Energy 
stent lead to a more or less comparable strut apposition, while the results suggest that the 
struts  of  the  Integrity  stent  are  generally  closer  to  the  vessel  wall  and  that  the  Promus 
Element leads to a higher amount of malapposed struts in the tested model configuration. A 
possible explanation of these observations can be found by comparing the MLA or MLD: the 
Integrity and Promus Element stent correspond respectively with the largest (6.85 mm²) and 
the smallest (6.45 mm²) luminal area. In other words, the Integrity stent results in a larger 
diameter as compared to the Promus Element stent when deploying both stents in the same 
stenosed vessel model (and at the same pressure). It seems reasonable to assume that a 
larger stent diameter leads to a better apposition of the stent struts.
The differences in  MLA and MLD as reported in  Table  2 are  the result  of  the complex 
mechanical  interaction  between  the  balloon,  stent  and  arterial  wall.  One  important 
observation is that the deployment of the different balloon-stent systems at 12 atm in open 
air (i.e. without surrounding tissue) leads to different stent diameters, because of variations in 
balloon compliance, initial  balloon diameter (at zero pressure) and resistance of the stent 
structure. The Promus Element stent results in the smallest stent diameter when expanded 
at 12 atm in open air and this partially explains why this stent leads to the smallest MLA. 
Logically, other aspects such as elastic recoil and radial strength (or stiffness) also affect the 
MLA.
The Integrity stent has struts with a circular cross-section, while all other included designs 
have  rectangular  struts.  The  measurement  procedure  used  to  quantify  the  strut-artery 
distance is slightly different for the circular and the rectangular struts and this may have an 
impact on the obtained apposition results. A strut with a rectangular cross-section might be 
partially in contact with the vessel wall but the applied measurement procedure might still  
indicate a gap between the strut and the vessel wall. 
For all stents, the zones with the best strut apposition are the diseased segments, which can 
be explained by the higher stent-artery ratio at these locations. Consequently, increasing the 
stent  diameter  in  the  non-diseased  segments  may  further  improve  the  overall  strut 
apposition. This finding confirms the importance of a tailored postdilation to minimize ISA 
[18]. The largest strut-artery distances are observed at the plaque shoulders, suggesting that 
segments with strong variations in luminal diameter are more prone to ISA.
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The stresses within the intimal layer were investigated as it has been suggested that these 
stresses in particular may act as a chronic stimulus for cell  proliferation [6]. Low stresses 
induced by stenting are preferred in order to minimize the arterial injury and the resulting 
healing response. However, increasing the diameter of a stenosed vessel inherently leads to 
high  circumferential  stresses.  Implanting  stents  in  curved  vessels  also  causes  vessel 
straightening and leads to increased axial (or longitudinal) stresses within the vessel wall, 
which could be minimized by using more flexible stents. Our results clearly show that the 
currently  available  stent  platforms  have  a  distinct  impact  on  the  vessel  wall  and  might 
therefore cause different levels of arterial injury.
All stents lead to stress peaks at the stent ends which may explain the frequent incidence of 
stent edge dissections [19]. These stress peaks may also contribute to the occurrence of 
restenosis immediately proximal or distal to the stented region. For example, Moses et al. 
[20] reported an in-stent restenosis rate of 3.2% when using sirolimus-eluting stents, but a 
restenosis rate of 8.9% was obtained by considering the stented vessel segment and the 
non-stented regions 5 mm proximal and distal to the stent.
It  should be noted that  the axial  stresses may also be influenced by the circumferential 
behaviour  of  the  different  stents.  The  stents  have  been  combined  with  different  balloon 
models in order to obtain realistic compliance behaviour for each balloon-stent system. In 
other  words,  deploying  the  stents  at  an  identical  pressure  will  lead  to  different  stent 
diameters. This, in combination with variations in stent recoil and stent compliance, will result 
in different stent diameters after balloon deflation.
Study limitations
All  results  should be interpreted carefully  as they are based on numerical  models which 
inherently contain a number of assumptions and approximations of which the most important 
are listed here:
-  Residual  stresses in  the  stents introduced by the crimping process are not  taken into 
account.
-  Virtual stent models were generated based on stent dimensions derived from micro-CT 
data. This process has been performed as accurately as possible, but it should be noted that 
the resulting stent models might slightly differ from the actual stent geometries (e.g. corner 
rounding of rectangular struts is neglected). In addition, only one sample of every stent was 
scanned  and  consequently,  possible  variations  in  strut  dimensions  between  different 
samples were neglected.
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- The material properties assigned to the stents are taken from [8] and might not fully reflect 
the real mechanical behaviour of the alloys (on stent level).
The observed differences in strut apposition, lumen gain and axial stress state between the 
investigated stents are only based on one single case (one vessel geometry, one inflation 
pressure,  one  stent  position,  one  set  of  material  data  for  the  arterial  wall)  and  should 
therefore not be generalized to other cases. In addition, further experimental validation of the 
proposed modelling strategy seems advised. Finally, it should be stressed that these tests 
may not be indicative of clinical performance.
Conclusion
The mechanical behaviour of the investigated stent designs differs considerably in terms of 
stent strut apposition (which was evaluated using a novel finite element based test), luminal 
gain  and  stent  induced  vessel  wall  stresses.  Stent  design  might  therefore  influence  the 
incidence of late stent thrombosis and the amount of arterial injury. The provided insights into 
the mechanical  behaviour  of  the  different  stents may help  to  understand and to  explain 
clinical observations.
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Tables
Table 1: Overview of the analyzed stents and some of their characteristics.
BMS DES Company
Nominal dimensions 
and pressure
Alloy
Integrity Integrity Resolute Medtronic 3.0 x 18 mm / 9 atm CoCr MP35N
Liberté / Veriflex Taxus Liberté Boston Scientific 3.0 x 16 mm / 9 atm SS316L
Multi-Link 8 Xience Prime Abbott Vascular 3.0 x 18 mm / 10 atm CoCr L605
Multi-Link Vision Xience V 1 Abbott Vascular 3.0 x 18 mm / 9 atm CoCr L605
Pro-Kinetic Energy - Biotronik 3.0 x 18 mm / 9 atm CoCr L605
- Promus Element ² Boston Scientific 3.0 x 16 mm / 12 atm PtCr
Most of the investigated stent designs are used as a BMS and as platform for a DES. (1 Also 
the  Promus  DES  (Boston  Scientific)  is  based  on  the  Multi-Link  Vision  stent  platform.  2 
Besides the Promus Element, the Taxus Element also uses the same platform, but elutes 
paclitaxel instead of everolimus).
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Table 2: Minimal luminal area (MLA) and minimal luminal diameter (MLD)
Stent MLA / MLD 
Integrity 6.85 mm² / 2.95 mm
Liberté 6.72 mm² / 2.93 mm
Multi-Link 8 6.69 mm² / 2.92 mm
Multi-Link Vision 6.58 mm² / 2.89 mm
Pro-Kinetic Energy 6.63 mm² / 2.91 mm
Promus Element 6.45 mm² / 2.87 mm
The MLA was measured at the two stenoses and the average values are given. The MLD 
was derived from the MLA, by assuming a circular shape of the luminal cross-sections.
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Figures
Figure 1: Cross-sectional view of the two vessel models. 
Stent  strut  apposition  was  evaluated  using  model  A,  while  stent  induced  stresses  were 
investigated in model B. The two asymmetric plaques are characterized by a percent area 
stenosis  of  61%.  The  four  different  colours  indicate  the  zones  with  different  material 
properties (plaque, intima, media and adventitia).
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Figure 2: Illustration of the simulated insertion and deployment procedure. 
The top panel shows the original configuration. The position of the balloon-stent system prior 
to balloon inflation is depicted in the second panel. The third panel shows the deformations 
at  the  maximum balloon  pressure,  while  the  final  configuration  after  balloon  deflation  is 
visualized in the bottom panel.
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Figure 3: Measurement of strut-artery distance
Assessment of the stent strut apposition requires a quantification of the distance between the 
stent struts and the inner surface of the arterial wall. For stents with rectangular struts, the 
distance  was  measured  between  the  arterial  wall  and  the  centerline  of  the  outer  (or 
abluminal) stent surface. In case of circular struts, the initial outermost point was taken for 
the distance measurement.
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Figure 4: Validation of the virtual stent deployment behaviour
The virtual deployment of the Integrity stent is shown on the left, while a real deployment is 
depicted  on  the  right.  The  deformations  predicted  by  the  finite  element  simulations 
correspond well with the experimentally observed deployment behaviour.
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Figure 5: Contourplot of the strut apposition of the different stent designs
The contourplots show the distance between the centerline on the outer strut surface and the 
inner surface of the arterial wall. A nonlinear colorscale has been used, with red reflecting 
values between 0.04 and 0.15 mm, in order to obtain a better differentiation at lower values. 
The maximum strut-artery distance for every stent is also reported.
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Figure 6: Comparison of the strut apposition of the different stent designs
The percentage of stent struts at a distance larger than 0.01 mm is depicted in order to 
quantitatively compare the strut apposition of the different stents.
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Figure 7: Comparison of the axial stresses caused by the different stent designs
The  95  percentile  of  the  axial  stresses  within  the  intima  was  calculated  in  order  to 
quantitatively compare the axial stresses caused by the different stent designs. Only 5% of 
the volume of the intima has a stress value higher than this 95 percentile.
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Figure 8: Comparison of the axial stress distribution after implantation of the different 
stents
These contourplots show the axial stresses at the interface between the intima and media. 
Stress peaks are mainly located at the stent ends and at the inner curvatures.
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